Global market for Musculoskeletal Disease to reach $57 billion by 2014

The global market for Musculoskeletal Disease was about $45 billion in 2009 and is expected to reach $57 billion by 2014, a compound annual growth rate (CAGR) of around 5% from 2009 through 2014.

Learn about the current pipeline of therapeutics and biomaterials utilized in the treatment of Musculoskeletal Diseases (MSDs), analyze the market and forecast for MSD therapeutics and treatments, and outline the key factors that will influence this therapeutic area in the next few years...

Use this report to:

• Assess the growth potential of musculoskeletal disease treatments over a 5-year period and understand the key factors that will influence this therapeutic area
• Learn how advances in biomaterials are being translated into viable products in the orthobiologics area, changing the way a number of related disease states are treated and creating more therapies and market opportunities
• Identify which marketing and distribution partnerships, technology platforms, and product development programs are likely to yield new targets and drugs that will reach the market in the next few years
• Formulate marketing and business plans based on usage projections in the major primary and secondary disease application areas.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.